ArticleFrontiers in oncology2024

Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression.

Huimin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.